The "TOP 10 Global Pharma Company" is seeking:
Novel in vitro models that mimic oral gingival tissue
They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading research-based pharmaceutical and healthcare company in the world, employing 100,000+ people in 100+ countries.
Licensing out of a novel and patented NO-donating molecule with strong inhibitory activity specifically against melanoma and breast cancer cell growth.

Farmavita.Net member is looking for license opportunities for a range of patches including active ingredients like Fentanyl citrate, Nicotine etc.
Please contact us if you are interested in this business opportunity.
Medinfar has several EU-CTD dossier of Generic Drugs to offer for international market: Aciclovir Oral suspension (80 mg/ml), Deflazacort (6 and 30 mg, tablets), Omeprazole (10, 20 and 40 mg, capsules) and Piroxicam (20 mg, dispersible tablets).
Member of Farmavita.Net is looking for exclusive license-in opportunity for innovative OTC/non-prescription product.
License territory would be region of central-east and southeast Europe (Poland, Czech R., Slovak R., Hungary, Slovenia, Croatia, Bosnia, Serbia, Macedonia, Bulgaria and Romania). Licensee is established company with well developed sales and distribution capability. Please, contact us for more details.
A company seeks a process of making high-affinity antibodies (or other substances) that can bind rapidly to antigens of large molecular sizes, such as proteins. Their aim is to develop a high-speed immune detection apparatus.

While the internet has altered the landscape in the retail sector and revolutionized the airline industry, pharmaceutical companies have been slow to take advantage of the marketing opportunities offered by the medium. With existing sales and marketing strategies widely considered unsustainable, the industry needs to evolve and engage with its customers online, or it risks being left behind.
Rajendra Jangde, Shailendra Saraf, Sanjay Daharwal*, Swarnlata Saraf
Institute of pharmacy,
Pt. Ravishankar Shukla University, Raipur(C.G.), India 492010
Corresponding author*

Patient recruitment and retention in clinical trials is the leading bottleneck in the new drug development pipeline. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials.

Nanotechnology is the emerging scientific field which includes the study of small, thin, carbon-based materials known as nanotubes (also called CNTs), which are becoming widely used in a plethora of products ranging from technologically advanced items utilized by NASA to everyday items used in the home. These nanotubes are increasingly popular due to their light weight and supreme strength, which is said to be stronger than steel.
Complete your profileThe more information you put into your profile the easier it is for others to find you. Compare your profile with those of other members. The more you put into the network, the more benefit you will derive from community. |